SARS-CoV-2 and Acetylsalicylic Acid (SARA)

Clinical trial NCT05073718 · COMPLETED

Trial details

NCT number: NCT05073718
Sponsor: Barcelona Institute for Global Health
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

SARS-CoV2 Infection Covid19

Start date: 2022-09-14
Primary completion: 2024-05-23
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.